Inventiva (IVA) Tax Provisions (2025)
Inventiva (IVA) recorded quarterly Tax Provisions of $3.5 million in Q2 2025.
Inventiva (IVA) Tax Provisions (2025) Analysis & Trends
Inventiva's Tax Provisions history runs 1 years deep, the most recent figure standing at $3.5 million for Q2 2025.
- In Q2 2025, Tax Provisions changed N/A year-over-year to $3.5 million; the TTM figure through Jun 2025 stood at $3.5 million (changed N/A YoY), while the FY2025 annual figure was $25609.0, down 92.34% from the prior year.
- Tax Provisions was $3.5 million for Q2 2025 at Inventiva.
- In the past five years, Tax Provisions ranged from a high of $3.5 million in Q2 2025 to a low of $3.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3.45 Mn |